[Recombinant interferon alfa-2b in the treatment of patients with skin melanoma].
An analysis was performed of early and remote results of inauguration in patients with primary-circumscribed skin melanoma of extremities and trunk of adjuvant endolymphatic interferon therapy. The results showed a statistically insignificant tendency to improve as per comparison of indices for 3-yr survival. Comparative analysis of the above indices among male patients of the study group and controls revealed statistically significant augmentation of the survival index following postoperative interferon therapy.
S I
SI
Korovin
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000601:surgery; D008875:Middle Aged; D011182:Postoperative Care; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins